Etiket: kanser tedavisi

AI Promises to Find Cancer Cure Within Our Lifetime, Says UK Tech Boss

Rene Haas, the CEO of Arm Holdings, a leading chip designer based in Cambridge, has sparked a wave of optimism in the medical world by claiming that

Rene Haas, the CEO of Arm Holdings, a leading chip designer based in Cambridge, has sparked a wave of optimism in the medical world by claiming that artificial intelligence (AI) could potentially discover a cure for cancer during our lifetime. This bold assertion comes as he discusses the transformative power of AI in developing new cancer treatments, emphasizing that current DNA modeling challenges are “too complex” for humans alone. However, Haas remains confident that with advancements in technology, computers will soon be able to tackle these intricate problems.

“Modelling a cell, modelling a human, modelling how a DNA marker is impacted by cancer—it’s a tough nut to crack,” he remarked during an interview on the BBC’s Big Boss Interview podcast. But here’s the kicker: as we input more data into these AI systems and they become increasingly sophisticated, Haas believes they will have the capability to crack the code. This could drastically shorten the timeline for developing effective treatments—years could be cut off the process, which is pretty substantial, if you ask me.

In labs like Haas’s, AI is being trained with real patient data, which brings a new level of personalization and accuracy in treatment development. Imagine AI sifting through mountains of data, learning from each patient sample to predict outcomes more effectively. This is where AI can really shine and deliver tangible benefits to patients in a big way.

But it doesn’t stop at healthcare. Haas highlighted the versatility of AI, saying these systems can learn and adapt to new tasks. Take service robots, for instance. A robot programmed to make a bed could easily learn to arrange towels or even clean trash bins. That’s the kind of flexibility we’re talking about here. Yet, some folks are a bit overzealous in predicting job losses due to machines; the reality is, many roles will evolve rather than disappear entirely.

It’s worth noting that Arm’s technology is already powering half of the AI data centers worldwide. This has led to a significant shift in their business, especially with the sale of their own microchips. Recently, Facebook’s parent company Meta reached out to Arm, requesting the development of the Arm AGI chip, and demand has reportedly been “off the charts.” Haas acknowledges the current supply constraints, stating, “We absolutely need more chip factories before we can put a data center in space.”

Despite the company’s sale to Japanese investors in 2016, Arm remains a critical player in the UK technology landscape, boasting a significant workforce in Cambridge. Haas insists that they are “by far and away the largest employer in Cambridge,” maintaining a strong local presence.

As the conversation around AI continues to evolve, there are growing concerns regarding its implications. The chief scientist at OpenAI has warned that no one is adequately prepared for the consequences of AI’s rapid advancements. Meanwhile, leading tech firms are sounding alarms that time is running out for effective cybersecurity measures.

So, what does this all mean for the future of AI and healthcare? Will we really see a cancer cure made possible through these technological marvels? Only time will tell, but the excitement in the air is undeniable…

Kaynak: Orijinal Haber

UK’s Tech Leader Claims AI Will Cure Cancer, But Chip Shortage Slows Progress

Rene Haas, the big cheese over at Arm Holdings, a chip design company rooted in Cambridge, has made some bold claims about the future of artificial i

Rene Haas, the big cheese over at Arm Holdings, a chip design company rooted in Cambridge, has made some bold claims about the future of artificial intelligence and cancer treatment. He’s saying that AI is set to uncover cancer cures that we mere mortals might never achieve in our lifetimes. Sounds like science fiction, right? But Haas believes that as we feed more data into these super-smart machines, they’ll crack complex problems, like how DNA markers react to cancer.

In an interview on the BBC’s Big Boss Interview podcast, Haas explained that modeling a cell or understanding how cancer affects DNA is currently a daunting task, almost “too complex” for today’s tech. But here’s the kicker: he’s convinced that with advancements in AI, these computers will eventually get there. “As we feed more and more of the models into these computers, they’re going to solve it,” he said, sounding pretty optimistic about the future of healthcare.

Now, let’s not forget the chip shortage that’s putting a damper on all this excitement. With AI booming and demand for chips skyrocketing, Haas pointed out that we’re in a “supply-constrained environment.” It’s like trying to build a house with no bricks! The industry desperately needs more chip factories to keep up with the increasing demand. If they want to launch a data center into space, they really need to step up their game.

Haas, who recently stepped down from AstraZeneca’s board, sees AI’s potential in the labs, where they’re training it on data generated from patient samples. This could significantly speed up the development of new treatments, cutting years off the typical timeline. “This is where AI delivers real benefit to patients,” he said. And he’s not just talking about a future far away; he’s referring to advancements happening right now.

He also touched on how AI-powered robots are revolutionizing various industries. These machines aren’t just mindless workers; they can learn, adapt, and be reprogrammed for new tasks. Imagine a robot initially designed to make a bed now learning how to arrange towels or take out the trash. Haas reassured that fears about mass job losses due to automation might be a bit overblown.

Arm Holdings has been riding the wave of AI advancements, and recently, tech giant Meta even asked them to develop the Arm AGI chip. Haas says the demand has been “off the charts.” But the ongoing chip shortage is a real struggle. “Can you get enough chips?” he asked, highlighting the urgent need for factories to keep pace with this rapidly evolving tech landscape.

As he wrapped up, Haas emphasized that despite the challenges, the future looks bright for AI and healthcare. But let’s keep our fingers crossed that the tech world can overcome these hurdles. Who knows? Maybe soon, we’ll see breakthroughs in cancer treatment that we never thought possible.

Kaynak: Orijinal Haber